查詢結果分析
相關文獻
- Biliary Atresia at the Dawn of a New Century
- Acquired Immunodeficiency Syndrome and Cytomegalovirus Gastritis in a Patient with Decompensated Liver Cirrhosis and Hepatocellular Carcinoma: Report of a Case
- Congenital Varicella Syndrome as an Unusual Cause of Congenital Malformation: Report of One Case
- Clinical Evaluation of Primary Biliary Cirrhosis in Chinese Patients without Serum Anti-Mitochondrial Antibody
- 在臺灣控制肝細胞癌及肝硬化盛行有關的研究與措施及其成效
- Infant Congenital Cataract Possibly Infected by a Cytomegalovirus or the Herpes Simplex Virus
- 皮膚泛黃
- 病毒性肝炎肝硬化論治
- Comparisons of Ultrasonography and Liver Function Tests in the Detection of Liver Cirrhosis due to Viral Hepatitis B or C
- B型肝炎病毒帶原者、慢性B型肝炎及肝硬化之脈波圖形研究
頁籤選單縮合
題 名 | Biliary Atresia at the Dawn of a New Century=膽道閉鎖在新世紀轉捩點上 |
---|---|
作 者 | 莊錦豪; 林哲男; | 書刊名 | 長庚醫學 |
卷 期 | 24:4 2001.04[民90.04] |
頁 次 | 頁217-228 |
分類號 | 417.5456 |
關鍵詞 | 膽道閉鎖; 病毒; 畸形; 膽管炎; 肝硬化; Biliary atresia; Virus; Malformation; Cholangitis; Liver cirrhosis; |
語 文 | 英文(English) |
英文摘要 | Biliary atresia is a unique disorder in pediatric surgery. The incidence is 1 in 3,500 to 20,000 live births, but the disorder accounts for more than half of the patients requiring liver transplantation. After Kasai operation, the 5- and 10-year survival rate without the need of transplantation are 37-48% and 18-28%, respectively. An infectious pathogen, particularly the virus, has long been implicated as the causative agent of biliary atresia, but none has ever been identified. Ductal plate malformation is likely to be important in the pathogenesis of biliary atresia. Earlier diagnosis is associated with a better prognosis and biliary atresia should be considered in the differential diagnosis of prolonged jaundice in any infants older than 2 weeks of age. The experience of the surgeon and surgical decade are determinant in achieving success of the Kasai operation. Postoperative cholangitis affects more than 45% of the patients receiving Kasai operation and the afflicted patients are at risk of cessation of bile flow and exacerbation of preexisting liver cirrhosis. Hepatic fibrosis starts at the moment when biliary atresia develops and the ongoing inflammation will end up with liver cirrhosis and hepatic failure in most patients, including some with adequate bile drainage. The inhibition of liver cirrhosis in mice or rats by gene therapy, such as telomere gene delivery, transduction with the hepatocyte growth factor gene or blockade of TGF-£]signaling, may provide a new strategy to rejuvenate the ailing liver associated with biliary atresia in the future.(Chang Gung Med J 2001;24:217-28) |
本系統中英文摘要資訊取自各篇刊載內容。